Online Peptide Therapy and Longevity Evaluations
Access licensed provider evaluations for compounded peptide therapy from home. Available options include CJC-1295, Epithalon, GHK-Cu, MOTS-C, Semax/Selank, Pinealon, sermorelin, tesamorelin and tesamorelin/ipamorelin.
Many products in this category are investigational and have limited human safety and effectiveness data. “Longevity” describes the wellness category and does not mean that these products have been proven to slow aging, extend lifespan or prevent age-related disease.
Choose a product below to review its information and begin a confidential medical evaluation. Completing an evaluation does not guarantee that treatment will be prescribed.
How Online Peptide Therapy Evaluations Work
Select a Product
Choose a peptide product to review its information, available supply options and important limitations.
Complete Your Medical Questionnaire
Provide accurate information about your medical history, medications, allergies, symptoms and treatment goals.
Receive a Good Faith Examination
A licensed medical provider reviews your information and determines whether the requested treatment is clinically appropriate. Additional questions, medical records or laboratory testing may be required.
Receive Treatment When Approved
If treatment is approved and lawfully available, the provider determines the formulation, dosage and administration schedule. The prescription is prepared by a qualified compounding pharmacy and shipped according to applicable requirements.
Current Peptide Therapy Options
B-12, Glutathione, NAD+, Sermorelin
CJC-1295 / Ipamorelin
Epithalon
Epithalon / GHK-Cu
GHK-Cu
MOTS-C
Semax/Selank
Sermorelin
Tesamorelin
Tesamorelin / Ipamorelin
CJC-1295
CJC-1295 is an investigational peptide studied for its interaction with growth hormone signaling pathways. Human clinical information remains limited, and its safety, effectiveness and long-term effects have not been established.
A licensed provider must review your medical history, medications and relevant risk factors before determining whether treatment may be considered.
GHK-Cu
GHK-Cu is a naturally occurring copper-binding peptide studied for its involvement in cellular signaling and tissue-related processes. Available research and safety considerations differ according to the formulation and route of administration.
Human safety data for injectable compounded GHK-Cu are limited. The provider and dispensing pharmacy determine whether an available formulation may be appropriate.
MOTS-C
MOTS-C is a mitochondrial-derived peptide being studied for its potential involvement in cellular signaling and metabolic processes. Human exposure and safety information are extremely limited, and its clinical benefits have not been established.
Epithalon
Epithalon, also spelled Epitalon, is an investigational peptide discussed in connection with cellular and age-related biological pathways. Evidence involving human use remains limited, and no anti-aging or longevity outcome is guaranteed or established.
Semax/Selank
Semax and Selank are investigational peptides studied for possible involvement in neurological, cognitive and stress-response pathways. Evidence supporting human wellness uses remains limited, and safety and effectiveness have not been established.
The provider will determine whether either peptide or an available compounded formulation can be considered based on individual medical factors and lawful availability.
Sermorelin
Sermorelin is a synthetic peptide that acts similarly to growth hormone-releasing hormone, which is involved in signaling the pituitary gland. It may be discussed in hormonal and wellness settings for its role in growth hormone signaling.
A provider may request laboratory testing or additional medical information before determining whether compounded sermorelin is appropriate.
Pinealon
Pinealon is an investigational short peptide discussed in peptide and longevity settings for its potential interaction with cellular and neurological pathways. Reliable human clinical evidence is limited, and its safety, effectiveness, appropriate dosage and long-term effects have not been established.
Tesamorelin
Tesamorelin is a growth hormone-releasing factor analog. FDA-approved tesamorelin has a specific indication for reducing excess abdominal fat in adults with HIV-associated lipodystrophy and is not approved for weight-loss management.
A compounded tesamorelin product is not FDA approved or interchangeable with an FDA-approved formulation. Any prescribing decision must be based on an individualized medical evaluation.
Medical Oversight for Investigational Peptides
The term “peptide therapy” covers many different substances with different biological actions, evidence levels and safety concerns. Products should not be treated as interchangeable simply because they are included in the same wellness category.
Purchasing a product or completing an evaluation does not guarantee a prescription. All treatment decisions are subject to provider discretion, clinical appropriateness, pharmacy requirements, state and federal regulations and product availability.
Most products in this category are compounded or investigational. Compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or manufacturing quality before marketing.
Important Safety Information
Provide a complete list of prescription medications, over-the-counter products and supplements during your evaluation. Tell the provider about cancer, diabetes, cardiovascular disease, endocrine disorders, pregnancy, breastfeeding or previous reactions to injectable medications.
Follow the dosage and administration instructions supplied by the provider and pharmacy. Never estimate a dose based on another peptide product because vial concentrations and prescribed quantities may differ.
Seek immediate medical care for difficulty breathing, facial or throat swelling, fainting, severe chest pain, a rapid or irregular heartbeat or signs of a serious allergic reaction.
About Compounded Medication
All options offered through this website are compounded medications. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before being marketed. Follow the exact dosing, administration, and storage instructions provided by your prescriber and dispensing pharmacy.